Covered recipient · General Payments record
ANKITA JAIN
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
This page merges CMS profile IDs 2796785, 8804291 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2020–2024
$484.42
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.09 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $68.19 | 2 |
| Acerta Pharma LLC | $67.52 | 3 |
| Amgen Inc. | $57.40 | 3 |
| Novo Nordisk AS | $53.84 | 2 |
| Janssen Biotech, Inc. | $41.78 | 1 |
| Lilly USA, LLC | $26.48 | 1 |
| HARMONY BIOSCIENCES LLC | $24.23 | 1 |
| Exact Sciences Corporation | $24.15 | 1 |
| Grifols USA, LLC | $24.11 | 1 |
| GlaxoSmithKline, LLC. | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.86 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103982904 | CMS |
| ABBVIE INC. | $33.33 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103982906 | CMS |
| Amgen Inc. | $25.75 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111607797 | CMS |
| Amgen Inc. | $16.65 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111607799 | CMS |
| Amgen Inc. | $15.00 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111607801 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.23 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105833031 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.67 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105470047 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.62 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105572401 | CMS |
| Exact Sciences Corporation | $24.15 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114716289 | CMS |
| GlaxoSmithKline, LLC. | $18.39 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116060300 | CMS |
| Grifols USA, LLC | $24.11 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719634 | CMS |
| HARMONY BIOSCIENCES LLC | $24.23 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126071420 | CMS |
| Janssen Biotech, Inc. | $41.78 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078701523 | CMS |
| Lilly USA, LLC | $26.48 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040618 | CMS |
| Novo Nordisk Inc | $24.54 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097653367 | CMS |
| Novo Nordisk Inc | $29.30 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097484044 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs
- 2796785, 8804291
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.